Freenome, Inc. (FRNM)

Freenome, Inc. (FRNM) is a healthcare company (diagnostics & research) based in the United States. The share price is $10.00, down 0.89% on the day, which values the company at $1.12B. Price as of 17 Nov 2026, 17:43 UTC, from Yahoo Finance.

Key facts

Share price
$10.00−0.89% today
Market value
$1.12B
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Freenome, Inc. in more detail

FRNM trades at -4.0× next year's expected earnings, 5.1× sales.

Worth checking: Altman Z in the distress zone; Beneish M-score flags the accounts.

2 of the superinvestors tracked here hold FRNM, including Andrew Spokes (0.3% of the portfolio), Cathie Wood (0.3% of the portfolio).

Superinvestors holding FRNM

2 of the investors tracked here report a position in their latest 13F filing.

Freenome, Inc. (FRNM): questions and answers

What is Freenome, Inc.'s market cap?

Freenome, Inc. is valued at $1.12B at a share price of $10.00.

Does FRNM pay a dividend?

Freenome, Inc. does not currently pay a regular dividend.

Which famous investors own FRNM?

In their latest quarterly filings, Andrew Spokes (0.3% of the portfolio), Cathie Wood (0.3% of the portfolio) hold FRNM. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Freenome, Inc. (FRNM) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/FRNM

Underlying data: Yahoo Finance; company filings with the SEC.